Product Reports Resources Pricing Login Book a demo
Startup list · Global

AI drug discovery startups

Below are the top global AI drug discovery startups, ranked by total funding. Together the 50 companies on this list have raised a combined $23B, and include 22 unicorns. The strongest hubs are United States, United Kingdom, China.

$23Bcombined funding · 50 companies
United Statestop hub
50companies shown
22unicorns

Ranked by total funding · Updated 2026-11-03 · Source: Dealroom

#CompanyFoundedHQFunding
1 Isomorphic LabsUnicorn An artificial intelligence company to discover new drugs 2021 London, United Kingdom $2.7B
2 MirendilUnicorn AI models for biology and materials science research 2026 San Francisco, United States $1.2B
3 Xaira TherapeuticsUnicorn Integrated biotechnology company focusing on leveraging artificial intelligence to transform drug discovery and development 2023 South San Francisco, United States $1.0B
4 Enveda BiosciencesUnicorn AI-native biotech discovering oral medicines from life's chemistry 2019 Boulder, United States $833M
5 Odyssey Therapeutics Building a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmune diseases 2018 Boston, United States $792M
6 XtalPiUnicorn Artificial intelligence (AI) pharmaceutical firm 2014 Shenzhen, China $785M
7 Generate BiomedicinesUnicorn Pioneering Generative Biology to create breakthrough medicines 2020 Somerville, United States $693M
8 ExscientiaUnicorn Applying artificial intelligence and big data processing to accelerate discovery and development of drugs 2012 Oxford, United Kingdom $675M
9 InsitroUnicorn Insitro is revolutionizing pharmaceutical R&D by leveraging machine learning for drug discovery 2018 San Francisco, United States $643M
10 Chai DiscoveryUnicorn AI-driven foundation models for predicting and reprogramming biochemical molecule interactions, enhancing drug discovery and molecular research 2024 San Francisco, United States $630M
11 Recursion PharmaUnicorn A clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery 2013 Salt Lake City, United States $599M
12 LifeMine Therapeutics Pioneering in genomically-enabled drug discovery approach integrating advanced life science and computational technologies 2017 Cambridge, United States $563M
13 Lila SciencesUnicorn Scientific superintelligence to tackle humanity's greatest challenges through AI-driven discovery and innovation 2022 Cambridge, United States $550M
14 Relay TherapeuticsUnicorn A new breed of company at the intersection of computation and biotechnology that is committed to creating medicines that will have a transformative impact on patients 2016 Cambridge, United States $550M
15 InSilico MedicineUnicorn Develops an AI platform for drug development to treat cancer and age-related diseases 2014 Cambridge, United States $532M
16 Formation BioUnicorn Technology company that helps bring treatments to patients faster 2013 New York City, United States $530M
17 Valo HealthUnicorn Cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process 2019 Lexington, United States $488M
18 Genuity Science Genomic information company using sequence data to improve health for people around the world 2013 Boston, United States $455M
19 BenevolentAIUnicorn BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company 2013 London, United Kingdom $454M
20 METiS TherapeuticsUnicorn AI-driven platform for drug discovery and delivery 2017 Cambridge, United States $405M
21 Genesis Molecular AI$25M+ revenueDealroom profile unavailable Unifying AI and Biotech We're pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines 2019 San Mateo, United States $400M
22 Schrodinger Computational drug designing for pharmaceutical and biotechnology research 1990 New York City, United States $373M
23 OwkinUnicorn Collaborative research platform and unique AI drug development solutions that make precision medicine a reality 2016 Paris, France $335M
24 Alto NeuroscienceDealroom profile unavailable Clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform 2019 Los Altos, United States $307M
25 Arbor Biotechnologies Diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability 2016 Cambridge, United States $305M
26 Iambic Therapeutics AI-driven chemistry for medicine 2019 San Diego, United States $303M
27 ImmunaiUnicorn Mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes 2019 New York City, United States $301M
28 ConcertAIUnicorn Accelerating insights and outcomes for patients through leading RWD, AI technology and scientific expertise 2017 Cambridge, United States $300M
29 Huma$25M+ revenue Provides a digital health platform used for predictive care and research 2011 London, United Kingdom $298M
30 BioAge Labs BIOAGE discovers and develops drugs to treat aging and associated diseases 2015 Emeryville, United States $294M
31 Anew LabsDealroom profile unavailable ByteDance-spun AI drug discovery for oral small-molecule immunology 2026 Yangpu District, China $290M
32 Soley Therapeutics Drug discovery and development company using cellular responses and AI to identify novel therapies for complex diseases 2020 Brentwood, United States $290M
33 Gritstone Oncology Developing next-generation personalized cancer therapeutics 2015 Emeryville, United States $261M
34 PathAI AI-powered pathology platform optimizing diagnostic accuracy and research 2016 Boston, United States $259M
35 Frontier Medicines Frontier Medicines, a South San Francisco, CA-based new pre-clinical stage biopharmaceutical company 2018 South San Francisco, United States $256M
36 Berkeley Lights$25M+ revenue BL is enabling cell by cell selection & manipulation to empower development, antibody discovery and engineering for personalized therapies 2011 Emeryville, United States $246M
37 Deep Genomics Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies 2014 Toronto, Canada $237M
38 Seismic Therapeutic The Machine Learning Immunology Company 2020 Watertown, United States $231M
39 AbSciUnicorn The global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry 2011 Vancouver, United States $228M
40 bit.bio Developing a scalable technology platform capable of producing consistent batches of every human cell 2016 Cambridge, United Kingdom $225M
41 Monte Rosa TherapeuticsUnicorn Developing next-generation small molecule protein degraders to treat cancer and beyond 2018 Boston, United States $224M
42 Basecamp Research AI protein and therapeutic design from biodiversity-scale genomic data 2019 London, United Kingdom $220M
43 Warp SciencesFast growingDealroom profile unavailable AI- and robotics-driven chemistry labs providing drug discovery services to biotech and pharma 2026 South San Francisco, United States $215M
44 Superluminal MedicinesFast growing Generative biology and chemistry company revolutionizing the speed and accuracy of how medicine is created 2023 Boston, United States $213M
45 Achilles Therapeutics Achilles Tx's mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells 2016 Stevenage, United Kingdom $208M
46 Asimov Synthetic biology company building tools to design living systems 2017 Boston, United States $205M
47 Stealth StartupDealroom profile unavailable Developing AI models for drug discovery, including tools to identify new uses for existing and failed medicines 2026 San Francisco, United States $200M
48 Predictive Oncology A leader in functional precision medicine harnessing the power of tumor to personalize therapy 2002 Pittsburgh, United States $198M
49 Terray Therapeutics Terray Therapeutics – A New Paradigm in Drug Discovery 2018 Pasadena, United States $195M
50 Scipher Medicine Bringing precision medicine to complex diseases through the power of network medicine 2015 Waltham, United States $192M

Track AI drug discovery startups worldwide

Get the full dataset — funding rounds, investors, signals and new entrants — in the Dealroom platform.

Book a demo